Simplex Trading
SRNE

Simplex Trading’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Simplex Trading’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-272,200
Closed -$97K – 10471
2023
Q1 		$97K Sell
272,200
-190,000
-41% -$170K ﹤0.01% 5189
2022
Q4 		$409K Buy
462,200
+50,300
+12% +$66.7K ﹤0.01% 3392
2022
Q3 		$646K Buy
411,900
+17,000
+4% +$38.6K ﹤0.01% 3167
2022
Q2 		$793K Buy
394,900
+213,900
+118% +$370K ﹤0.01% 2884
2022
Q1 		$421K Sell
181,000
-896,500
-83% -$2.8M ﹤0.01% 4063
2021
Q4 		$5.01M Buy
1,077,500
+457,500
+74% +$2.84M 0.01% 1201
2021
Q3 		$6.81M Buy
620,000
+36,100
+6% +$306K 0.01% 960
2021
Q2 		$5.66M Buy
+583,900
New +$4.65M 0.01% 1075
2021
Q1 		– Sell
-6,021
Closed -$4.11M – 10399
2020
Q4 		$4.11M Sell
6,021
-2,006
-25% -$16.1K 0.01% 1135
2020
Q3 		$8.95M Buy
8,027
+331
+4% +$3.03K 0.01% 564
2020
Q2 		$4.83M Buy
7,696
+4,737
+160% +$18.1K 0.01% 870
2020
Q1 		$544K Buy
2,959
+903
+44% +$2.6K ﹤0.01% 2500
2019
Q4 		$694K Buy
2,056
+1,460
+245% +$3.48K ﹤0.01% 2415
2019
Q3 		$127K Sell
596
-1,203
-67% -$2.8K ﹤0.01% 4061
2019
Q2 		$480K Buy
1,799
+488
+37% +$1.76K ﹤0.01% 2606
2019
Q1 		$622K Buy
1,311
+824
+169% +$2.16K ﹤0.01% 2431
2018
Q4 		$116K Buy
487
+421
+638% +$1.38K ﹤0.01% 3721
2018
Q3 		$29K Sell
66
-1,016
-94% -$5.63K ﹤0.01% 5682
2018
Q2 		$779K Buy
1,082
+535
+98% +$3.64K ﹤0.01% 2009
2018
Q1 		$18K Buy
547
+516
+1,665% +$3.67K ﹤0.01% 3484
2017
Q4 		$3K Buy
+31
New +$81 ﹤0.01% 5026
2017
Q1 		– Sell
-54
Closed -$6K – 6990
2016
Q4 		$6K Sell
54
-54
-50% -$324 ﹤0.01% 4252
2016
Q3 		$8K Buy
108
+2
+2% +$13 ﹤0.01% 3867
2016
Q2 		$7K Buy
106
+83
+361% +$530 ﹤0.01% 3976
2016
Q1 		$1K Sell
23
-498
-96% -$2.9K ﹤0.01% 5294
2015
Q4 		$59K Buy
521
+228
+78% +$1.92K ﹤0.01% 1794
2015
Q3 		$13K Buy
293
+201
+218% +$3.2K ﹤0.01% 3225
2015
Q2 		$13K Buy
92
+38
+70% +$488 ﹤0.01% 2862
2015
Q1 		$8K Buy
+54
New +$625 ﹤0.01% 3155

Other funds holding SRNE

SW
SlateStone Wealth Jupiter, Florida $1.31B AUM 26.51% 1-Year Est. Return
KA
KLCM Advisors Milwaukee, Wisconsin $1.19B AUM 34.45% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
AA
AlphaMark Advisors Ft. Wright, Kentucky $231M AUM 19.98% 1-Year Est. Return
OAJ
Ogorek Anthony Joseph Williamsville, New York $365M AUM 18.21% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return
CFGS
Concourse Financial Group Securities Birmingham, Alabama $1.77B AUM 17.37% 1-Year Est. Return

Simplex Trading's SRNE Position: Q4 2022 in Review

Simplex Trading sold out of Sorrento Therapeutics, Inc. (SRNE) in Q4 2022, closing a stake of 147,289 shares — an estimated $195K sold.

Simplex Trading first reported a position in SRNE in Q1 2015 and held it in 11 quarters. The position peaked at $497K in Q2 2022. 223 funds tracked by Wall St. Rank hold SRNE as of Q4 2022.

  • Simplex Trading reported no remaining Sorrento Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
  • Simplex Trading sold 147,289 Sorrento Therapeutics, Inc. shares in Q4 2022, an estimated $195K.
  • Simplex Trading first reported a position in Sorrento Therapeutics, Inc. in Q1 2015 and held it in 11 quarters.
  • Simplex Trading's Sorrento Therapeutics, Inc. position peaked at $497K in Q2 2022.
  • 223 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q4 2022.

Based on Simplex Trading's 13F filing for Q4 2022, filed 2 Feb 2023.